Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical efficacy of abatacept in Japanese rheumatoid arthritis patients.
Takahashi N, Kojima T, Terabe K, Kaneko A, Kida D, Hirano Y, Fujibayashi T, Yabe Y, Takagi H, Oguchi T, Miyake H, Kato T, Fukaya N, Ishikawa H, Hayashi M, Tsuboi S, Kato D, Funahashi K, Matsubara H, Hattori Y, Hanabayashi M, Hirabara S, Yoshioka Y, Ishiguro N. Takahashi N, et al. Among authors: tsuboi s. Mod Rheumatol. 2013 Sep;23(5):904-12. doi: 10.1007/s10165-012-0760-4. Epub 2012 Sep 14. Mod Rheumatol. 2013. PMID: 22975734
Clinical efficacy of abatacept compared to adalimumab and tocilizumab in rheumatoid arthritis patients with high disease activity.
Takahashi N, Kojima T, Kaneko A, Kida D, Hirano Y, Fujibayashi T, Yabe Y, Takagi H, Oguchi T, Miyake H, Kato T, Fukaya N, Ishikawa H, Hayashi M, Tsuboi S, Kanayama Y, Kato D, Funahashi K, Matsubara H, Hattori Y, Hanabayashi M, Hirabara S, Terabe K, Yoshioka Y, Ishiguro N. Takahashi N, et al. Among authors: tsuboi s. Clin Rheumatol. 2014 Jan;33(1):39-47. doi: 10.1007/s10067-013-2392-2. Epub 2013 Sep 22. Clin Rheumatol. 2014. PMID: 24057092 Free PMC article.
Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study.
Takahashi N, Kojima T, Kaneko A, Kida D, Hirano Y, Fujibayashi T, Yabe Y, Takagi H, Oguchi T, Miyake H, Kato T, Fukaya N, Hayashi M, Tsuboi S, Kanayama Y, Funahashi K, Hanabayashi M, Hirabara S, Asai S, Yoshioka Y, Ishiguro N. Takahashi N, et al. Among authors: tsuboi s. Rheumatology (Oxford). 2015 May;54(5):854-9. doi: 10.1093/rheumatology/keu418. Epub 2014 Oct 21. Rheumatology (Oxford). 2015. PMID: 25339638
Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry.
Fujibayashi T, Takahashi N, Kida D, Kaneko A, Hirano Y, Fukaya N, Yabe Y, Oguchi T, Tsuboi S, Miyake H, Takemoto T, Kawasaki M, Ishiguro N, Kojima T. Fujibayashi T, et al. Among authors: tsuboi s. Mod Rheumatol. 2015;25(6):825-30. doi: 10.3109/14397595.2015.1029238. Epub 2015 Apr 30. Mod Rheumatol. 2015. PMID: 25775147
Clinical effectiveness and long-term retention of abatacept in elderly rheumatoid arthritis patients: Results from a multicenter registry system.
Takahashi N, Kojima T, Kida D, Kaneko A, Hirano Y, Fujibayashi T, Yabe Y, Takagi H, Oguchi T, Hanabayashi M, Kato T, Funahashi K, Hayashi M, Tsuboi S, Kanayama Y, Sobue Y, Asai N, Matsumoto T, Watanabe T, Asai S, Ishiguro N. Takahashi N, et al. Among authors: tsuboi s. Mod Rheumatol. 2019 Nov;29(6):910-918. doi: 10.1080/14397595.2018.1525019. Epub 2018 Oct 25. Mod Rheumatol. 2019. PMID: 30220237
Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysis.
Takahashi N, Kojima T, Kida D, Kaneko A, Hirano Y, Fujibayashi T, Yabe Y, Takagi H, Oguchi T, Hanabayashi M, Kato T, Funahashi K, Hayashi M, Tsuboi S, Kanayama Y, Sobue Y, Asai N, Matsumoto T, Watanabe T, Asai S, Ishiguro N. Takahashi N, et al. Among authors: tsuboi s. Clin Rheumatol. 2019 Sep;38(9):2451-2459. doi: 10.1007/s10067-019-04581-7. Epub 2019 May 17. Clin Rheumatol. 2019. PMID: 31102087
Association between seropositivity and discontinuation of tumor necrosis factor inhibitors due to ineffectiveness in rheumatoid arthritis.
Ogawa Y, Takahashi N, Kaneko A, Hirano Y, Kanayama Y, Yabe Y, Oguchi T, Fujibayashi T, Takagi H, Hanabayashi M, Funahashi K, Hayashi M, Tsuboi S, Asai S, Asai N, Matsumoto T, Sobue Y, Ishiguro N, Kojima T. Ogawa Y, et al. Among authors: tsuboi s. Clin Rheumatol. 2019 Oct;38(10):2757-2763. doi: 10.1007/s10067-019-04626-x. Epub 2019 Jun 10. Clin Rheumatol. 2019. PMID: 31179526
Higher doses of methotrexate associated with discontinuation of oral glucocorticoids after initiation of biological DMARDs: A retrospective observational study based on data from a Japanese multicenter registry study.
Suzuki M, Kojima T, Takahashi N, Asai S, Terabe K, Kaneko A, Hirano Y, Hanabayashi M, Oguchi T, Takagi H, Kanayama Y, Yabe Y, Funahashi K, Fujibayashi T, Tsuboi S, Ito T, Yoshioka Y, Ishikawa H, Sobue Y, Nishiume T, Yokota Y, Ishiguro N. Suzuki M, et al. Among authors: tsuboi s. Mod Rheumatol. 2021 Jul;31(4):796-802. doi: 10.1080/14397595.2021.1879428. Epub 2021 Feb 25. Mod Rheumatol. 2021. PMID: 33492191
441 results